Business
Press Release Feb 24 2023
Strides Pharma Science Limited has informed the Exchange regarding a press release dated February 24, 2023, titled "Strides flagship facility in Bangalore receives USFDA inspection closure".
About this update from Strides Pharma Science Ltd
[{"type":"text","content":" Strides Pharma Science Limited has informed the Exchange regarding a press release dated February 24, 2023, titled \"Strides flagship facility in Bangalore receives USFDA inspection closure\". View Attachment","length":338,"tagName":"div"}]